首页> 外文期刊>Journal of vascular and interventional radiology: JVIR >Comparison of SMART stent placement for arteriovenous graft salvage versus successful graft PTA.
【24h】

Comparison of SMART stent placement for arteriovenous graft salvage versus successful graft PTA.

机译:比较SMART支架置入动静脉移植物和成功移植PTA。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

PURPOSE: To compare the SMART (shape memory alloy recoverable technology) stent with percutaneous transluminal angioplasty (PTA) alone in hemodialysis access venous stenoses. MATERIALS AND METHODS: A prospective, nonrandomized study was undertaken in 60 patients with dysfunctional polytetrafluoroethylene dialysis grafts. Indications for stent placement were acute PTA failure, rapid restenosis, and vessel perforation. The primary endpoint was improved graft patency in patients treated with stents compared with that in patients whose disease responded to PTA alone. The secondary endpoints were lower postprocedural midgraft pressures and similar complication rates compared with PTA alone. RESULTS: The key venous stenosis was at the graft-to-vein anastomosis in all but two patients. Thirty-five patients showed a response to PTA alone. Sixteen patients received stents for stenoses greater than 30% after angioplasty, six for rapidly recurrent stenosis, and three for venous rupture. Nine patients received stents across the level of the elbow joint. Stenosis after intervention was significantly less frequent in the stent group (7% vs 16%; P = .001), but the midgraft systolic pressure ratios did not significantly differ. The clinical success rates were 100% after stent implantation and 97% after PTA alone. Except for venous rupture, there were no procedure-related complications, and, excluding early graft thrombosis, there were no complications at 30 days. A single stent fracture was found on follow-up. The mean primary graft patency times were 5.6 months after PTA and 8.2 months after stent treatment (P = .050). When stents were placed across the level of the elbow joint, the mean primary graft patency time was 8.9 months. CONCLUSION: Implantation of the SMART stent is safe and effective for the treatment of residual or rapidly recurrent dialysis access venous stenoses and is associated with better patency than PTA alone.
机译:目的:比较血液透析通路静脉狭窄中的SMART(形状记忆合金可回收技术)支架与单独的经皮腔内血管成形术(PTA)。材料与方法:对60例功能异常的聚四氟乙烯透析移植物患者进行了一项前瞻性,非随机性研究。支架放置的指征为急性PTA衰竭,快速再狭窄和血管穿孔。与仅对PTA有反应的患者相比,使用支架治疗的患者的主要终点指标是改善的移植通畅性。与仅使用PTA相比,次要终点是较低的术后移植中压和相似的并发症发生率。结果:除两名患者外,其余所有患者的关键静脉狭窄均发生在移植物与静脉的吻合处。 35名患者仅对PTA有反应。血管成形术后有16例患者的狭窄度大于30%,而快速复发的狭窄有6例,静脉破裂有3例。 9名患者在整个肘关节水平接受了支架。支架组介入后狭窄的发生率明显降低(7%vs 16%; P = .001),但移植中段的收缩压比没有显着差异。支架植入后的临床成功率为100%,仅PTA后的临床成功率为97%。除静脉破裂外,没有与手术相关的并发症,并且除了早期的移植物血栓形成外,在30天时没有任何并发​​症。随访发现单个支架断裂。平均一次移植通畅时间为PTA后5.6个月和支架治疗后8.2个月(P = .050)。当在肘关节水平放置支架时,平均初次移植通畅时间为8.9个月。结论:SMART支架的植入对于残余或快速复发性透析通路静脉狭窄的治疗是安全有效的,并且比单独使用PTA具有更好的通畅性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号